34 Results for "

GCase

" in MedChemExpress (MCE) Product Catalog:
Products (34)

34 Results for "GCase" in MCE Product Catalog:

13
13 Publications Verification
Cat. No.: HY-100944
CAS No.: 6090-95-5
Purity:  99.92%
Target:  

Glycosidase

Research Areas:  

Neurological Disease

Conduritol B epoxide is an irreversible covalently bound acid β-glucosidase (GCase) inhibitor.
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-B1039A
CAS No.: 23828-92-4
Synonyms: NA-872 hydrochloride
Ambroxol hydrochloride (NA-872 hydrochloride), an active metabolite of the proagent Bromhexine, has potent expectorant effects. Ambroxol hydrochloride is a glucocerebrosidase (GCase) chaperone and increases glucocerebrosidase activity. Ambroxol hydrochloride induces lung autophagy and has the potential for Parkinson disease and neuronopathic Gaucher disease research .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-B1039
CAS No.: 18683-91-5
Synonyms: NA-872
Ambroxol (NA-872), an active metabolite of the proagent Bromhexine, has potent expectorant effects. Ambroxol is a glucocerebrosidase (GCase) chaperone and increases glucocerebrosidase activity. Ambroxol induces lung autophagy and has the potential for Parkinson disease and neuronopathic Gaucher disease research .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-120034
CAS No.: 1462267-07-7
Purity:  99.53%
NCGC 607 is a noninhibitory small-molecule chaperone of glucocerebrosidase (GCase). NCGC 607 can increase GCase activity, reduce α-synuclein levels, and decrease glycolipid levels. NCGC 607 can be used in the research of Gaucher disease and Parkinson's disease .
loading...
    loading...
Cat. No.: HY-14829
CAS No.: 169105-89-9
Purity:  99.96%
Synonyms: D-Isofagomine; Isofagomine
Target:  

Glycosidase

Research Areas:  

Neurological Disease

Afegostat is a pharmacological chaperone, which specifically and reversibly binds acid-β-glucosidase (GCase) in the endoplasmic reticulum (ER) with high affinity .
loading...
    loading...
Cat. No.: HY-139452
CAS No.: 209540-62-5
Purity:  99.96%
Target:  

Glycosidase

Research Areas:  

Others

PFB-FDGlu is a selective lysosomal Glucocerebrosidase (GCase) substrate, which is metabolised by GCase to yield fluorescein. PFB-FDGlu is cell permeable and can be used with a flow cytometer to measure GCase activity in living cells on a single-cell basis .
loading...
    loading...
Cat. No.: HY-104038
CAS No.: 1919820-28-2
Purity:  99.11%
Synonyms: LTI-291; BIA 28-6156
Target:  

Glycosidase

Research Areas:  

Neurological Disease Endocrinology

Pariceract (LTI-291) is an activator of glucocerebrosidase (Gcase), with activation rates of more than 60% (1 μM) and between 10%-20% (0.1 μM). Pariceract can be used for Parkinson's disease and endometriosis research .
loading...
    loading...
Cat. No.: HY-147976
CAS No.: 2279945-76-3
Target:  

Glycosidase

Glucocerebrosidase-IN-1 (compound 11a) is a potent and selective GCase (glucocerebrosidase) inhibitor, with an IC50 of 29.3 μM and a Ki of 18.5 μM. Glucocerebrosidase-IN-1 can be used for the research of Gaucher disease (GD) and Parkinson’s disease (PD) .
loading...
    loading...
Cat. No.: HY-114615
CAS No.: 216758-20-2
Purity:  99.7%
Synonyms: AMP-DNM
AMP-Deoxynojirimycin (AMP-DNM) is a potent ceramide glucosyltransferase and GCase 2 inhibitor. AMP-Deoxynojirimycin also is a GlcCer biosynthesis inhibitor .
loading...
    loading...
Cat. No.: HY-174311
CAS No.: 2648407-76-3
Target:  

Glycosidase

GT-02216 can bind to GCase allosterically and enhance its activity. GT-02216 enhances the activity of GCase in primary human fibroblasts dose-dependently reduces the accumulation of its substrate, hexosylsphingosine (HexCer). GT-02216 reduces the Tau accumulation in mutant GBA1 fibroblasts. GT-02216 can be used for the study of Parkinson’s disease .
loading...
    loading...
Cat. No.: HY-14829E
CAS No.: 957230-65-8
Purity:  ≥98.0%
Synonyms: D-Isofagomine D-Tartrate; Isofagomine D-Tartrate
Target:  

Glycosidase

Research Areas:  

Neurological Disease

Afegostat D-Tartrate is a pharmacological chaperone, which specifically and reversibly binds acid-β-glucosidase (GCase) in the endoplasmic reticulum (ER) with high affinity .
loading...
    loading...
Cat. No.: HY-154823
CAS No.: 2759897-35-1
Purity:  99.23%
Target:  

Glycosidase

Research Areas:  

Metabolic Disease

Gcase activator 2 (compound 14), a pyrrolo[2,3-b]pyrazine, is alos a β-Glucocerebrosidase (GCase) activator (EC50=3.8 μM). Gcase activator 2 induces GCase dimerizatio (both K-type and V-type). And Gcase activator 2 has low metabolic clearance in human and mouse .
loading...
    loading...
Cat. No.: HY-117861
CAS No.: 1380716-06-2
Purity:  ≥98.0%
Target:  

Glycosidase

Research Areas:  

Metabolic Disease

ML198 is a glucocerebrosidase (GCase) modulator with an EC50 of 0.4 μM. ML198 is an activator and non-inhibitory chaperone of glucocerebrosidase. ML198 can be used for the research of Gaucher disease . ML198 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
loading...
    loading...
Cat. No.: HY-B1039AS
CAS No.: 2741380-71-0
Synonyms: NA-872-d5 hydrochloride
Ambroxol-d5 (hydrochloride) is the deuterium labeled Ambroxol hydrochloride. Ambroxol hydrochloride (NA-872 hydrochloride), an active metabolite of the proagent Bromhexine, has potent expectorant effects. Ambroxol hydrochloride is a glucocerebrosidase (GCase) chaperone and increases glucocerebrosidase activity. Ambroxol hydrochloride induces lung autophagy and has the potential for Parkinson disease and neuronopathic Gaucher disease research .
loading...
    loading...
Cat. No.: HY-160426
CAS No.: 2270984-21-7
Target:  

Glycosidase

Research Areas:  

Neurological Disease

Gcase activator 3 (compound 9Q) is a glucosidase (Glucosidase, GCase) activator that can partially stabilize GCase and increase its activity. Gcase activator 3 reduces mutant GCase protein misfolding and degradation in fibroblasts and dopaminergic midbrain neurons. Gcase activator 3 can be used in the study of Parkinson's disease (PD) and related synucleinopathies .
loading...
    loading...
Cat. No.: HY-B1039AR
CAS No.: 23828-92-4
Synonyms: NA-872 hydrochloride (Standard)
Ambroxol (hydrochloride) (Standard) is the analytical standard of Ambroxol (hydrochloride). This product is intended for research and analytical applications. Ambroxol hydrochloride (NA-872 hydrochloride), an active metabolite of the proagent Bromhexine, has potent expectorant effects. Ambroxol hydrochloride is a glucocerebrosidase (GCase) chaperone and increases glucocerebrosidase activity. Ambroxol hydrochloride induces lung autophagy and has the potential for Parkinson disease and neuronopathic Gaucher disease research .
loading...
    loading...
Cat. No.: HY-D1575
CAS No.: 170212-26-7
C6 NBD galactosylceramide is an active derivative of galactosylceramide that is tagged with fluorescent C6 nitrobenzoxadiazole (C6 NBD). C6 NBD galactosylceramide can be used as a substrate for neutral β-glycosylceramidase (GCase) to study intracellular localization and metabolism of galactosylceramide (Ex=nm, Em=525) .
loading...
    loading...
Cat. No.: HY-147976A
CAS No.: 2279945-77-4
Target:  

Glycosidase

Research Areas:  

Neurological Disease

Glucocerebrosidase-IN-1 (compound 11a) hydrochloride is a potent and selective GCase (glucocerebrosidase) inhibitor, with an IC50 of 29.3 μM and a Ki of 18.5 μM. Glucocerebrosidase-IN-1 hydrochloride can be used for the research of Gaucher disease (GD) and Parkinson’s disease (PD) .
loading...
    loading...
Cat. No.: HY-156287
CAS No.: 796079-91-9
Purity:  ≥97.0%
Target:  

Glycosidase

Research Areas:  

Cancer

GCase modulator-1 (compound 9g), a derivative of Quinazoline, is a modulator of GCase (Glucosidase) (AC50=2.23 μM) .
loading...
    loading...
Cat. No.: HY-B1039C
CAS No.: 96989-76-3
Synonyms: NA-872 acefylline; Acebrophylline
Ambroxol (NA-872) acefylline, an active metabolite of the proagent Bromhexine, has potent expectorant effects. Ambroxol acefylline is a glucocerebrosidase (GCase) chaperone and increases glucocerebrosidase activity. Ambroxol acefylline induces lung autophagy and has the potential for Parkinson disease and neuronopathic Gaucher disease research .
loading...
    loading...